High levels of MUC1 cell surface expression [29,30], reported immunosuppressive activities of its released ectodomain [31] and anti-adhesive properties [32,33] all contribute to the ability of the MUC1 antigen to protect and promote tumor cell growth and survival, making MUC1 an attractive target for cancer immunotherapy. This evidence concerns the gene MUC1 and neoplasm.